Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG: In vitro study

Journal of Neuro-Oncology

Volumn 47, Issue 2, 2000, Pages 133-140

  Yoshida, D ^a   Hoshino, S ^a   Shimura, T ^a   Takahashi, H ^a   Teramoto, A ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; DNA; Estramustine; Glioma

Indexed keywords

ESTRAMUSTINE PHOSPHATE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; ONCOLOGY;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BRAIN NEOPLASMS; DNA FRAGMENTATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRAMUSTINE; GLIOMA; HUMANS; MICROSCOPY, ELECTRON; MICROTUBULES; ORGANELLES; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0033847546     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006393705560     Document Type: Article

References (37)

1. Coupling cell division and cell death to microtubule dynamics
2. In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate
3. Multiple centrosomal microtubule organising centres and inversed microtubule stability are early features of VP-16-induced apoptosis in CCRF-CEM cells
4. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53
5. Apoptosis in cancer therapy
6. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
7. Mitotic block induced in HeLa cells by low concentrations of peclitaxol (Taxol) results in abnormal mitotic exit and apototic cell death
8. Cytoskeleton remodeling during growth cone-target interactions
9. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway
10. DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain - suggesting an apoptotic cell death
11. Estramustine in malignant glioma
12. Targeting microtubule-associated proteins in glioblastoma: A new strategy for selective therapy
13. Estramustine-binding and specific binding protein of the anti-mitotic compound estramustine in astrocytoma
14. Specific binding of estramustine to prostatic proteins
15. Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau
16. The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells
17. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3
18. Clinical and biological studies of estramustine phosphate as a radiation sensitizer
19. Estramustine: A novel radiation enhancer in human carcinoma cells
20. Estramustine sensitizes human glioblastoma cells to irradiation
21. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: In vitro study
22. Distribution of estramustine in the BT4C rat glioma model
23. Phase 2 study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer
24. A study of the conditions and mechanisms of the diphenylalamine reaction for the colorimetric estimation of deoxyribonucleic acid
25. Accumulation of estramustine and estromustine in adipose tissue of rats and humans
26. Effects of estramustine on DNA and cell membrane in malignant glioma cells
27. Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells
28. Uptake and retension of estramustine and presence of estramustine binding protein in malignant brain tumours in humans
29. Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmatic reticulum, and inhibits cell migration
30. Estramustine depolymerizes microtubules by binding to tubulin
31. Early morphological detection of estramustine cytotoxity measured as alteration in cell size and shape by a new technique of microperifusion
32. Selective antimitotic effects of estramustine correlate with its anti-microtubule properties on glioblastoma and astrocytes
33. Evidence that estramustine binds MAP-1 A to inhibit type IV collagenase secretion
34. Estramustine binding protein in human brain-tumor tissue
35. Regulation by Bcl-2 family proteins and its role in cancer and chemoresistance
36. Mechanisms of apoptosis' integration of genetic, biochemical and cellular factors
37. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle